37 results on '"Rüther, E."'
Search Results
2. P.2.c.017 Cardiological changes during antidepressant treatment with SSRIs – a drug surveillance report of German-speaking countries
3. Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing
4. Time course of antipsychotic treatment response in schizophrenia: Results from a naturalistic study in 280 patients
5. P.2.098 EEG abnormalities in patients treated with quetiapine
6. P.1.137 Autoimmune thyroiditis (AIT) and affective disorders — a prospective pilot study
7. Homocysteine induces cell death of rat astrocytes in vitro
8. 5-HT1A responsivity in patients with panic disorder before and after treatment with aerobic exercise, clomipramine or placebo
9. Hyperhomocysteinemia as a new risk factor for brain shrinkage in patients with alcoholism
10. Risperidone in the initial treatment of acutely exacerbated schizophrenic patients
11. Effects on body temperature in new atypical antipsychotic drugs
12. Oxidative stress and an altered methionine metabolism in alcoholism
13. Adverse effects of the comedication of neuroleptics and antidepressants
14. Diurnal variation of cortisol in panic disorder
15. The relevance of serum carbamazepine levels in affective and schizoaffective disorders
16. Doxepin in the treatment of primary insomnia — A placebo-controlled, double-blind, polysomnographic study
17. Treatment habits with respect to risperidone in acute psychiatry in Germany
18. Efficacy of risperidone on affective symptoms in acute schizophrenia
19. Increased psychological responses and divergent neuroendoerins responses to ipsapirone and m-CPP in patients with panic disorder
20. P.3.005 Panic disorder and agoraphobia: What is effective?
21. P.3.006 Panic disorder and agoraphobia: An aetiological model
22. P.6.020 Is there a physiological coupling between melatoni and glucocorticoids?
23. P.3.004 The application of the panic and agoraphobia scale (PAS) in clinical trials
24. P.3.003 Salivary cortisol in panic disorder
25. P.6.021 Rebound insomnia after abrupt hypnotic withdrawal
26. Salivary cortisol in panic disorder
27. Panic disorder and agoraphobia: What is effective?
28. Efficacy measurement with the new panic and agoraphobia scale by using a new nonparametric test for repeated measures
29. Panic disorder and agoraphobia: What is effective?
30. Urinary excretion of cortisol, norepinephrine, epinephrine, testosterone, and melatonin in panic disorder
31. P-5-16 Panic disorder — acceptance of the diagnostic entity and preferred treatment
32. P-5-14 What treatments do patients with panic disorder and agoraphobia get?
33. Benzodiazepine dependence: detoxification under standardized conditions
34. Treatment of schizophrenia
35. Effect of sodium-valproate on CSF GABA, cAMP, cGMP and homovanillic acid levels in men
36. 3,4-Dihydroxyphenylacetic acid and homovanillic acid in serum and cerebrospinal fluid of psychotic patients estimated by a gas chromatographic method
37. Benzodiazepine dependence — aetiological factors, time course, consequences and withdrawal symptomatology: a study of five cases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.